-
公开(公告)号:US4411893A
公开(公告)日:1983-10-25
申请号:US422891
申请日:1982-09-24
CPC分类号: A61K47/18 , A61K47/22 , A61K9/0014 , Y10S514/947 , Y10S514/975
摘要: Topical therapeutic compositions are disclosed which contain from about 0.1 to 70 percent by weight of a water-soluble tertiary amine oxide and a therapeutic agent selected from the group consisting of erythromycin, benzoyl peroxide, hydrocortisone, tetracycline, 5-fluorouracil, and propranolol. The amine oxide enhances penetration of the therapeutic agent into and through the skin.
摘要翻译: 公开了含有约0.1至70重量%的水溶性叔胺氧化物和选自红霉素,过氧化苯甲酰,氢化可的松,四环素,5-氟尿嘧啶和普萘洛尔的治疗剂的局部治疗组合物。 氧化胺增强了治疗剂穿透皮肤并穿过皮肤。
-
公开(公告)号:US4544629A
公开(公告)日:1985-10-01
申请号:US443155
申请日:1982-11-19
申请人: Thomas K. Rice , Therese A. Senta
发明人: Thomas K. Rice , Therese A. Senta
CPC分类号: G01N33/94 , Y10S435/81 , Y10S435/975 , Y10S436/808 , Y10S436/811
摘要: A receptor-based clinical or research competitive inhibition assay method for determining histamine in body or laboratory fluids is disclosed. A kit for carrying out the method is also described comprising an amount of histamine receptors sufficient to provide an excess of receptors for binding with the amount of histamine in the sample to be assayed, and an amount of a histamine-indicator conjugate sufficient to react with the resulting unbound histamine receptors present after reaction of the histamine sample with the histamine receptors.
摘要翻译: 公开了一种用于测定身体或实验室液体中的组胺的基于受体的临床或研究竞争性抑制测定方法。 还描述了用于实施该方法的试剂盒,其包含足以提供过量受体以与要测定的样品中的组胺量结合的组胺受体,以及足以与 在组胺样品与组胺受体反应后存在的未结合的组胺受体。
-